p62/SQSTM1 – steering the cell through health and disease
暂无分享,去创建一个
[1] Dao K. H. Nguyen,et al. Autophagy as a common pathway in amyotrophic lateral sclerosis , 2019, Neuroscience Letters.
[2] A. Spada,et al. TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: Molecular mechanisms, cellular processes, and emerging therapeutic opportunities , 2019, Neurobiology of Disease.
[3] R. Huganir,et al. Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver Disease. , 2018, Cell metabolism.
[4] N. Dokholyan,et al. p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2 , 2018, Molecular and Cellular Biology.
[5] J. Moscat,et al. Metabolic reprogramming of the tumor microenvironment by p62 and its partners. , 2018, Biochimica et biophysica acta. Reviews on cancer.
[6] A. Brech,et al. Starvation induces rapid degradation of selective autophagy receptors by endosomal microautophagy , 2018, The Journal of cell biology.
[7] R. Donato,et al. Nrf2-Keap1 signaling in oxidative and reductive stress. , 2018, Biochimica et biophysica acta. Molecular cell research.
[8] In-geun Ryoo,et al. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance , 2018, Redox biology.
[9] N. Mizushima. A brief history of autophagy from cell biology to physiology and disease , 2018, Nature Cell Biology.
[10] N. Perrimon,et al. Blocking p62‐dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes , 2018, The Journal of clinical investigation.
[11] Jing Zhao,et al. P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity. , 2018, The Biochemical journal.
[12] M. Tschöp,et al. Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor. , 2018, Cancer cell.
[13] C. Garbutt,et al. Expression and Clinical Implication of Autophagy-Associated Protein p62 in Osteosarcoma , 2018, Oncology.
[14] Z. Elazar,et al. Mechanism and medical implications of mammalian autophagy , 2018, Nature Reviews Molecular Cell Biology.
[15] Michael L Lu,et al. Aberrant subcellular localization of SQSTM1/p62 contributes to increased vulnerability to proteotoxic stress recovery in Huntington's disease , 2018, Molecular and Cellular Neuroscience.
[16] Ming-Rong Wang,et al. Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition , 2018, Oncogene.
[17] Pilong Li,et al. Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation , 2018, Cell Research.
[18] A. Ciechanover,et al. N-terminal arginylation generates a bimodal degron that modulates autophagic proteolysis , 2018, Proceedings of the National Academy of Sciences.
[19] I. Rahman,et al. Nrf2 mediates the expression of BAG3 and autophagy cargo adaptor proteins and tau clearance in an age-dependent manner , 2018, Neurobiology of Aging.
[20] R. Youle,et al. Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance , 2018, Current Biology.
[21] Guanghui Wang,et al. Cereblon suppresses the formation of pathogenic protein aggregates in a p62-dependent manner , 2018, Human molecular genetics.
[22] Kee K. Kim,et al. Autophagy-mediated upregulation of cytoplasmic claudin 1 stimulates the degradation of SQSTM1/p62 under starvation. , 2018, Biochemical and biophysical research communications.
[23] C. Sachse,et al. p62 filaments capture and present ubiquitinated cargos for autophagy , 2018, The EMBO journal.
[24] Elsje G. Otten,et al. Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis , 2018, Nature Communications.
[25] S. Kageyama,et al. Negative Regulation of the Keap1-Nrf2 Pathway by a p62/Sqstm1 Splicing Variant , 2018, Molecular and Cellular Biology.
[26] S. Arii,et al. DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma , 2018, Scientific Reports.
[27] M. Goedert,et al. Galectin-8–mediated selective autophagy protects against seeded tau aggregation , 2017, The Journal of Biological Chemistry.
[28] Masakazu Yamamoto,et al. Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis , 2017, Experimental animals.
[29] A. Ciechanover,et al. Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathway , 2017, Autophagy.
[30] M. Karin,et al. Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. , 2017, Cancer cell.
[31] Bei Lan,et al. The prognostic value of p62 in solid tumor patients: a meta-analysis , 2017, Oncotarget.
[32] C. Viret,et al. Autophagy in Measles Virus Infection , 2017, Viruses.
[33] B. Lu,et al. Conformation-dependent recognition of mutant HTT (huntingtin) proteins by selective autophagy , 2017, Autophagy.
[34] Wannian Yang,et al. The HECT E3 ubiquitin ligase NEDD4 interacts with and ubiquitylates SQSTM1 for inclusion body autophagy , 2017, Journal of Cell Science.
[35] Hongting Zheng,et al. Multifunctional p62 Effects Underlie Diverse Metabolic Diseases , 2017, Trends in Endocrinology & Metabolism.
[36] J. Tapia,et al. Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS , 2017, Proceedings of the National Academy of Sciences.
[37] N. Mizushima,et al. Monitoring and Measuring Autophagy , 2017, International journal of molecular sciences.
[38] Z. Qian,et al. VPS34 stimulation of p62 phosphorylation for cancer progression , 2017, Oncogene.
[39] C. Hagedorn,et al. Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture , 2017, Scientific Reports.
[40] Chunze Zhang,et al. The prognostic value of NRF2 in solid tumor patients: a meta-analysis , 2017, Oncotarget.
[41] Min Jae Lee,et al. p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis , 2017, Nature Communications.
[42] K. Lim,et al. p62-Mediated mitochondrial clustering attenuates apoptosis induced by mitochondrial depolarization. , 2017, Biochimica et biophysica acta. Molecular cell research.
[43] Eun-Kyoung Kim,et al. Phosphorylation of p62 by AMP-activated protein kinase mediates autophagic cell death in adult hippocampal neural stem cells , 2017, The Journal of Biological Chemistry.
[44] Liankun Sun,et al. p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1‐NF‐κB pathway in human ovarian cancer cells , 2017, Cancer science.
[45] C. Behl,et al. The Role of the Multifunctional BAG3 Protein in Cellular Protein Quality Control and in Disease , 2017, Front. Mol. Neurosci..
[46] R. Langer,et al. Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer , 2017, Oncotarget.
[47] R. Mahieux,et al. Distinct Contributions of Autophagy Receptors in Measles Virus Replication , 2017, Viruses.
[48] T. Chou,et al. Keap1/Cullin3 Modulates p62/SQSTM1 Activity via UBA Domain Ubiquitination. , 2017, Cell reports.
[49] G. Manikhas,et al. Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors , 2017, Oncotarget.
[50] L. Hui,et al. Ubiquitylation of p62/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress , 2017, Cell Research.
[51] D. Sabatini,et al. mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.
[52] M. Collins,et al. TBK1: a new player in ALS linking autophagy and neuroinflammation , 2017, Molecular Brain.
[53] G. Prins,et al. Arsenic Induces p62 Expression to Form a Positive Feedback Loop with Nrf2 in Human Epidermal Keratinocytes: Implications for Preventing Arsenic-Induced Skin Cancer , 2017, Molecules.
[54] J. Ninomiya-Tsuji,et al. TAK1 Regulates the Nrf2 Antioxidant System Through Modulating p62/SQSTM1. , 2016, Antioxidants & redox signaling.
[55] Huikyong Lee,et al. ENC1 Modulates the Aggregation and Neurotoxicity of Mutant Huntingtin Through p62 Under ER Stress , 2016, Molecular Neurobiology.
[56] Masaki Tanaka,et al. HSF1 stress response pathway regulates autophagy receptor SQSTM1/p62-associated proteostasis , 2016, Autophagy.
[57] S. Subramaniam,et al. p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer. , 2016, Cancer cell.
[58] B. Cha,et al. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. , 2016, Free radical biology & medicine.
[59] Young Ho Suh,et al. Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy , 2016, PloS one.
[60] T. Hawley,et al. Noncanonical SQSTM1/p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, metabolic and translational reprogramming , 2016, Oncotarget.
[61] O. Riess,et al. Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro , 2016, Neuropharmacology.
[62] Kwang-Soo Kim,et al. LRRK2 interferes with aggresome formation for autophagic clearance , 2016, Molecular and Cellular Neuroscience.
[63] A. Caccamo,et al. p62 improves AD-like pathology by increasing autophagy , 2016, Molecular Psychiatry.
[64] H. Shang,et al. Functional links between SQSTM1 and ALS2 in the pathogenesis of ALS: cumulative impact on the protection against mutant SOD1-mediated motor dysfunction in mice. , 2016, Human molecular genetics.
[65] Ken-ichi Inoue,et al. Accumulation of phosphorylated p62 is associated with NF‐E2‐related factor 2 activation in hepatocellular carcinoma , 2016, Journal of hepato-biliary-pancreatic sciences.
[66] Jingxia Li,et al. Upregulation of SQSTM1/p62 contributes to nickel-induced malignant transformation of human bronchial epithelial cells , 2016, Autophagy.
[67] J. Neefjes,et al. An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport , 2016, Cell.
[68] Zhijie Kang,et al. p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA , 2016, Oncogene.
[69] Shujiro Okuda,et al. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming , 2016, Nature Communications.
[70] S. Subramaniam,et al. p62, Upregulated during Preneoplasia, Induces Hepatocellular Carcinogenesis by Maintaining Survival of Stressed HCC-Initiating Cells. , 2016, Cancer cell.
[71] J. Choe,et al. Enhanced p62 Is Responsible for Mitochondrial Pathway-Dependent Apoptosis and Interleukin-1β Production at the Early Phase by Monosodium Urate Crystals in Murine Macrophage , 2016, Inflammation.
[72] J. Choe,et al. Erratum to: Enhanced p62 is Responsible for Mitochondrial Pathway-Dependent Apoptosis and Interleukin-1β Production at the Early Phase by Monosodium Urate Crystals in Murine Macrophage , 2016, Inflammation.
[73] R. Langer,et al. Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas , 2016, Oncotarget.
[74] R. Langer,et al. Prognostic value of the autophagy markers LC3 and p62/SQSTM1 in early-stage non-small cell lung cancer , 2016, Oncotarget.
[75] Robert Layfield,et al. Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD , 2016, Autophagy.
[76] W. Zong,et al. TRIM21 Ubiquitylates SQSTM1/p62 and Suppresses Protein Sequestration to Regulate Redox Homeostasis. , 2016, Molecular cell.
[77] Jian-feng Dong,et al. P62: An emerging oncotarget for osteolytic metastasis , 2016, Journal of bone oncology.
[78] N. Hattori,et al. Serine 403-phosphorylated p62/SQSTM1 immunoreactivity in inclusions of neurodegenerative diseases , 2016, Neuroscience Research.
[79] Zheng Tan,et al. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson’s disease , 2016, Protein & Cell.
[80] E. Esen,et al. Inclusion bodies enriched for p62 and polyubiquitinated proteins in macrophages protect against atherosclerosis , 2016, Science Signaling.
[81] D. Tang,et al. Activation of the p62‐Keap1‐NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells , 2016, Hepatology.
[82] I. Narita,et al. Sqstm1–GFP knock-in mice reveal dynamic actions of Sqstm1 during autophagy and under stress conditions in living cells , 2015, Journal of Cell Science.
[83] C. Romá-Mateo,et al. Ubiquitin conjugating enzyme E2-N and sequestosome-1 (p62) are components of the ubiquitination process mediated by the malin-laforin E3-ubiquitin ligase complex. , 2015, The international journal of biochemistry & cell biology.
[84] H. Ren,et al. Bcl-2 Decreases the Affinity of SQSTM1/p62 to Poly-Ubiquitin Chains and Suppresses the Aggregation of Misfolded Protein in Neurodegenerative Disease , 2015, Molecular Neurobiology.
[85] A. Schapira,et al. Mitochondrial and lysosomal biogenesis are activated following PINK1/parkin‐mediated mitophagy , 2015, Journal of neurochemistry.
[86] R. Deberardinis,et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer , 2015, Nature Genetics.
[87] Jeong Su Park,et al. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity. , 2015, Biochemical and biophysical research communications.
[88] K. Itoh,et al. p62 Deficiency Enhances α‐Synuclein Pathology in Mice , 2015, Brain pathology.
[89] A. Durán,et al. Amino Acid Activation of mTORC1 by a PB1-Domain-Driven Kinase Complex Cascade. , 2015, Cell reports.
[90] A. Pestronk,et al. SQSTM1 splice site mutation in distal myopathy with rimmed vacuoles , 2015, Neurology.
[91] Jacques P. Brown,et al. Paget’s disease of bone: an osteoimmunological disorder? , 2015, Drug design, development and therapy.
[92] M. Stumvoll,et al. Autophagy in adipose tissue of patients with obesity and type 2 diabetes , 2015, Molecular and Cellular Endocrinology.
[93] Terje Johansen,et al. The selective autophagy receptor p62 forms a flexible filamentous helical scaffold. , 2015, Cell reports.
[94] H. Bellen,et al. Huntingtin Functions as a Scaffold for Selective Macroautophagy , 2015, Nature Cell Biology.
[95] M. Sabbieti,et al. Plasmid DNA-coding p62 as a bone effective anti-inflammatory/anabolic agent , 2015, Oncotarget.
[96] M. L. Lachenmayer,et al. Proteotoxic Stress Induces Phosphorylation of p62/SQSTM1 by ULK1 to Regulate Selective Autophagic Clearance of Protein Aggregates , 2015, PLoS genetics.
[97] M. Hayden,et al. Autophagy in Huntington disease and huntingtin in autophagy , 2015, Trends in Neurosciences.
[98] J. Inazawa,et al. High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer , 2014, Acta histochemica et cytochemica.
[99] M. Cui,et al. p62/SQSTM1 is involved in cisplatin resistance in human ovarian cancer cells via the Keap1-Nrf2-ARE system. , 2014, International journal of oncology.
[100] G. Baillie,et al. PKA phosphorylation of p62/SQSTM1 regulates PB1 domain interaction partner binding. , 2014, Biochimica et biophysica acta.
[101] D. Gozal,et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. , 2014, Cell metabolism.
[102] M. Sherman,et al. Pilot study of p62 DNA vaccine in dogs with mammary tumors , 2014, Oncotarget.
[103] J. Moscat,et al. Interaction of SQSTM1 with the motor protein dynein – SQSTM1 is required for normal dynein function and trafficking , 2014, Journal of Cell Science.
[104] H. Jaeschke,et al. Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy. , 2014, Journal of hepatology.
[105] Christian M. Metallo,et al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. , 2014, Cancer cell.
[106] M. Searle,et al. SQSTM1 mutations--bridging Paget disease of bone and ALS/FTLD. , 2014, Experimental cell research.
[107] F. Gianfrancesco,et al. Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function , 2014, Biochimica et biophysica acta.
[108] Chein-Hui Hung,et al. Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma , 2014, British Journal of Cancer.
[109] I. Rahman,et al. Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52 , 2014, Nature Communications.
[110] T. Mizushima,et al. Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1 , 2013, Molecular and Cellular Biology.
[111] S. Horswell,et al. Prognostic impact of p62 expression in cutaneous malignant melanoma , 2013, The Journal of investigative dermatology.
[112] M. Sherman,et al. Broad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector , 2013, Oncotarget.
[113] T. Mizushima,et al. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. , 2013, Molecular cell.
[114] T. Sakurai,et al. Deficiency of p62/Sequestosome 1 Causes Hyperphagia Due to Leptin Resistance in the Brain , 2013, The Journal of Neuroscience.
[115] M. Pasparakis,et al. K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. , 2013, Molecular cell.
[116] Jia Fu,et al. Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer , 2013, OncoTargets and therapy.
[117] S. Gultekin,et al. LC3 and p62 as Diagnostic Markers of Drug-induced Autophagic Vacuolar Cardiomyopathy: A Study of 3 Cases , 2013, The American journal of surgical pathology.
[118] Kunxi Zhang,et al. Food restriction-induced autophagy modulates degradation of mutant SOD1 in an amyotrophic lateral sclerosis mouse model , 2013, Brain Research.
[119] J. Moscat,et al. A role for sequestosome 1/p62 in mitochondrial dynamics, import and genome integrity. , 2013, Biochimica et biophysica acta.
[120] Tsung-Teh Wu,et al. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy , 2013, Cancer biology & therapy.
[121] C. Shaw,et al. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant , 2013, Acta Neuropathologica.
[122] A. Walch,et al. p62 links β-adrenergic input to mitochondrial function and thermogenesis. , 2013, The Journal of clinical investigation.
[123] T. Hortobágyi,et al. An MND/ALS phenotype associated with C9orf72 repeat expansion: Abundant p62‐positive, TDP‐43‐negative inclusions in cerebral cortex, hippocampus and cerebellum but without associated cognitive decline , 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.
[124] T. Johansen,et al. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation , 2012, Journal of Cell Science.
[125] Steven B. Bradfute,et al. TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. , 2012, Immunity.
[126] J. M. Bravo-San Pedro,et al. The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts , 2012, Autophagy.
[127] Masaaki Komatsu,et al. Keap1 degradation by autophagy for the maintenance of redox homeostasis , 2012, Proceedings of the National Academy of Sciences.
[128] H. Aburatani,et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. , 2012, Cancer cell.
[129] S. Ralston,et al. Pathogenesis of Paget Disease of Bone , 2012, Calcified Tissue International.
[130] H. Kubo,et al. Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma , 2012, Cancer science.
[131] M. Hung,et al. KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[132] N. Nukina,et al. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. , 2011, Molecular cell.
[133] Aleksey A. Porollo,et al. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. , 2011, Molecular cell.
[134] T. Lamark,et al. Plant NBR1 is a selective autophagy substrate and a functional hybrid of the mammalian autophagic adapters NBR1 and p62/SQSTM1 , 2011, Autophagy.
[135] M. Shirakawa,et al. Crystal Structure of the Ubiquitin-associated (UBA) Domain of p62 and Its Interaction with Ubiquitin* , 2011, The Journal of Biological Chemistry.
[136] Keiji Tanaka,et al. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells , 2011, The Journal of cell biology.
[137] Y. Eishi,et al. Autophagy-deficient mice develop multiple liver tumors. , 2011, Genes & development.
[138] D. Rubinsztein,et al. Protein misfolding disorders and macroautophagy , 2011, Current opinion in cell biology.
[139] Jacques P. Brown,et al. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease. , 2011, Cell metabolism.
[140] R. Youle,et al. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both , 2010, Autophagy.
[141] Ramars Amanchy,et al. Phosphorylation of p62 by cdk1 Controls the Timely Transit of Cells through Mitosis and Tumor Cell Proliferation , 2010, Molecular and Cellular Biology.
[142] M. Komatsu,et al. Selective degradation of p62 by autophagy , 2010, Seminars in Immunopathology.
[143] Nobutaka Hattori,et al. p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria , 2010, Genes to cells : devoted to molecular & cellular mechanisms.
[144] She Chen,et al. Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy , 2010, Autophagy.
[145] M. McMahon,et al. p62/SQSTM1 Is a Target Gene for Transcription Factor NRF2 and Creates a Positive Feedback Loop by Inducing Antioxidant Response Element-driven Gene Transcription* , 2010, The Journal of Biological Chemistry.
[146] E. White,et al. A Noncanonical Mechanism of Nrf2 Activation by Autophagy Deficiency: Direct Interaction between Keap1 and p62 , 2010, Molecular and Cellular Biology.
[147] G. Bjørkøy,et al. p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy , 2010, Autophagy.
[148] Mihee M. Kim,et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 , 2010, Nature Cell Biology.
[149] P. Pfluger,et al. A functional role for the p62–ERK1 axis in the control of energy homeostasis and adipogenesis , 2010, EMBO reports.
[150] M. Williamson,et al. Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signalling. , 2010, Journal of molecular biology.
[151] Fabienne C. Fiesel,et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.
[152] G. Bjørkøy,et al. Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies* , 2009, The Journal of Biological Chemistry.
[153] J. Gal,et al. Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin‐independent mechanism , 2009, Journal of neurochemistry.
[154] M. Wooten,et al. Oxidative damage to the promoter region of SQSTM1/p62 is common to neurodegenerative disease , 2009, Neurobiology of Disease.
[155] Ivan Dikic,et al. NBR1 co-operates with p62 in selective autophagy of ubiquitinated targets , 2009, Autophagy.
[156] D. Lawrence,et al. Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling , 2009, Cell.
[157] M. Gearing,et al. Age-associated oxidative damage to the p62 promoter: implications for Alzheimer disease. , 2009, Free radical biology & medicine.
[158] T. Mizushima,et al. Structural Basis for Sorting Mechanism of p62 in Selective Autophagy* , 2008, Journal of Biological Chemistry.
[159] Junmin Peng,et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration , 2008, Journal of neurochemistry.
[160] Shao-Cong Sun,et al. Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. , 2008, The Journal of clinical investigation.
[161] J. Flores,et al. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. , 2008, Cancer cell.
[162] Masaaki Komatsu,et al. Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice , 2007, Cell.
[163] M. LaVoie,et al. The effects of oxidative stress on parkin and other E3 ligases , 2007, Journal of neurochemistry.
[164] S. Yokoyama,et al. Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response , 2007, Molecular and Cellular Biology.
[165] Fujian Zhang,et al. p62 Accumulates and Enhances Aggregate Formation in Model Systems of Familial Amyotrophic Lateral Sclerosis* , 2007, Journal of Biological Chemistry.
[166] Tsutomu Ohta,et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. , 2006, Molecular cell.
[167] J. Auwerx,et al. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. , 2006, Cell metabolism.
[168] G. Bjørkøy,et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death , 2005, The Journal of cell biology.
[169] Masaaki Komatsu,et al. Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice , 2005, The Journal of cell biology.
[170] Manuel Serrano,et al. The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. , 2004, Developmental cell.
[171] Jacques P. Brown,et al. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. , 2002, American journal of human genetics.
[172] K. Zatloukal,et al. Mallory body—A disease‐associated type of sequestosome , 2002, Hepatology.
[173] D. Klionsky,et al. Autophagy in the Eukaryotic Cell , 2002, Eukaryotic Cell.
[174] E. Kuusisto,et al. Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies , 2001, Neuroreport.
[175] H. Nakano,et al. The atypical PKC‐interacting protein p62 channels NF‐κB activation by the IL‐1–TRAF6 pathway , 2000, The EMBO journal.
[176] M. Diaz-Meco,et al. The interaction of p62 with RIP links the atypical PKCs to NF‐κB activation , 1999, The EMBO journal.
[177] M. Diaz-Meco,et al. Localization of Atypical Protein Kinase C Isoforms into Lysosome-Targeted Endosomes through Interaction with p62 , 1998, Molecular and Cellular Biology.
[178] A. Puls,et al. Interaction of protein kinase C zeta with ZIP, a novel protein kinase C-binding protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[179] N. Dokholyan,et al. 8-20-2018 p 62-dependent phase separation of patient-derived KEAP 1 mutations and NRF 2 , 2018 .
[180] M. Altshuler,et al. The diagnosis and natural history of Huntington disease. , 2017, Handbook of clinical neurology.
[181] S. Mendrinos,et al. Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score. , 2014, Urologic oncology.
[182] Manho Kim,et al. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux. , 2012, Human molecular genetics.
[183] Kurt Zatloukal,et al. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. , 2002, The American journal of pathology.